SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001640334-23-000534
Filing Date
2023-03-31
Accepted
2023-03-31 16:16:06
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 NT 20-F nymox_nt20f.htm NT 20-F 34096
  Complete submission text file 0001640334-23-000534.txt   35178
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: NT 20-F | Act: 34 | File No.: 001-12033 | Film No.: 23787886
SIC: 2835 In Vitro & In Vivo Diagnostic Substances